-
Uncategorized2 months agoSTAT+: Utah medical board calls for immediate suspension of state’s AI doctor experiment
Utah’s high-profile experiment with using an artificial intelligence system to renew prescriptions without physician oversight is facing its first major challenge as doctors in the state...
-
Uncategorized2 months ago
AI in Oncology Takes Off, Tackling HIV and Liver Disease, Pharma’s Recent Gains
Some GEN editors were in sunny San Diego covering the hottest research, trends, and products from the American Association for Cancer Research meeting. We kick things...
-
Uncategorized2 months agoSTAT+: Up and Down the Ladder: The latest comings and goings
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send...
-
Uncategorized2 months agoSanofi MS drug rejected in US gets an endorsement in Europe
Tolebrutinib, which the FDA recently turned back due to safety concerns, received a positive recommendation that positions the therapy for its first regulatory approval.
-
Uncategorized2 months ago
FDA awards priority vouchers to 3 undisclosed companies for investigational psychedelics
While the FDA did not announce the recipient names of the Commissioner’s National Priority Vouchers, the agency’s descriptions of the awarded products match those in development...
-
Uncategorized2 months ago
Compass, Usona and Transcend score FDA national priority vouchers amid Trump administration’s psychedelic push
The FDA is awarding national priority vouchers to Compass Pathways, Usona Institute and Transcend Therapeutics for their psychedelic treatments. A third recipient in this batch is...
-
Uncategorized2 months ago
Avalyn plots $182M IPO; WHO prequalifies Novartis’ malaria drug
Avalyn Pharma plots $182M IPO: The biotech, which is making inhaled versions of approved pulmonary fibrosis medicines, anticipates about $182 million in net proceeds if it...
-
Uncategorized2 months agoLilly tumbles on Foundayo’s shaky week; FDA to issue vouchers for psychedelics
Lilly shares dipped, and Novo’s climbed, as Foundayo’s early trajectory diverged from that of oral Wegovy. Elsewhere, Regeneron inked a drug price deal and two companies announced...
-
Uncategorized2 months ago
Exclusive: UC Berkeley startup bets on jumping genes for GLP-1 gene therapy
The new generation of weight loss medicines does an unprecedented job of keeping off the pounds — if people stay on the drugs. Yet numerous studies...
-
Uncategorized2 months agoInternational childhood vaccine campaign grows
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. It’s my birthday tomorrow. Read the rest… Read...
Hantavirus One-Shot mRNA Vaccine Fully Protects in Syrian Hamster Model
SonoThera Raises $125M to Develop Ultrasound-Mediated Genetic Medicines
